Philogen S.p.A.
PHIL.MIDrugs in Pipeline
13
Phase 3 Programs
2
Upcoming Catalysts
1
Next Catalyst
Oct 2026
Market Overview
Stock performance and key metrics
1 upcoming, 0 past
Daromun
Melanoma Stage IIIB
L19IL2 + L19TNF
Malignant Melanoma
Onfekafusp alfa
Glioblastoma
L19IL2/L19TNF
Melanoma Stage III
Dacarbazine
Soft Tissue Sarcoma
L19TNFa
Solid Tumors
L19TNF
Glioma of Brain
131I-F16SIP Radioimmunotherapy (RIT)
Cancer
Lomustine
Glioblastoma
L19IL2
Locally Advanced Basal Cell Carcinoma
Intratumoral injections of L19IL2
Malignant Melanoma
L19IL2+L19TNF
Malignant Melanoma, Skin
F16IL2 in combination with paclitaxel
Solid Tumor
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Daromun | Phase 3 | Melanoma Stage IIIB | - | - |
L19IL2 + L19TNF | Phase 3 | Malignant Melanoma | - | - |
Onfekafusp alfa | Phase 2 | Glioblastoma | - | - |
L19IL2/L19TNF | Phase 2 | Melanoma Stage III | - | - |
Dacarbazine | Phase 2 | Soft Tissue Sarcoma | - | - |
L19TNFa | Phase 2 | Solid Tumors | - | - |
L19TNF | Phase 2 | Glioma of Brain | - | - |
131I-F16SIP Radioimmunotherapy (RIT) | Phase 2 | Cancer | - | - |
Lomustine | Phase 2 | Glioblastoma | - | - |
L19IL2 | Phase 2 | Locally Advanced Basal Cell Carcinoma | - | - |
Intratumoral injections of L19IL2 | Phase 2 | Malignant Melanoma | - | - |
L19IL2+L19TNF | Phase 2 | Malignant Melanoma, Skin | - | - |
F16IL2 in combination with paclitaxel | Phase 2 | Solid Tumor | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Philogen S.p.A.'s drug pipeline?→
CatalystAlert tracks 13 drug candidates in Philogen S.p.A.'s (PHIL.MI) pipeline across Phase 3, Phase 2. Its lead program is Daromun (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Philogen S.p.A.'s next FDA catalyst?→
Philogen S.p.A.'s (PHIL.MI) next tracked catalyst is a Phase 2 expected October 15, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track PHIL.MI biotech catalysts?→
Add PHIL.MI to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Philogen S.p.A.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.